Yıl: 2015 Cilt: 30 Sayı: 3 Sayfa Aralığı: 206 - 213 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Comparison of Glucocorticoid and Nonsteroidal Anti-Inflammatory Drug Requirement Before and After Tumor Necrosis Factor Inhibitor Treatment in Patients With Rheumatoid Arthritis

Öz:
Objectives: This study aims to investigate whether use of nonsteroidal anti-inflammatory drugs (NSAIDs) or glucocorticoids (GCs) decreases over different time intervals before and after anti-tumor necrosis factor (anti-TNF) therapy in rheumatoid arthritis (RA) patients. Patients and methods: Data were extracted from electronic prescription records of the Pension Fund of Turkey covering records from the years 2000 to 2005 to detect patients aged 18 years or older who were administered anti-TNF agents. All TNF blockers, NSAIDs and GCs which were available in the market were our target of investigation. Patients were categorized into three groups defined by duration of continuous anti-TNF use (episode-1: >90 days, episode-2: >180 days, episode-3: >365 days). First anti-TNF prescription detected in the database was identified as the index prescription and its date was taken as the start date of therapy. GC and NSAID consumptions during the first three, six and 12 months before initiation of anti-TNF agents were compared with the subsequent same duration of consumptions after the initiation of anti-TNF agents. Results: Comparison of GC consumptions in each paired-durations of six and 12 months before and after anti-TNF therapy revealed significantly decreased mean daily GC intake. Achieved reduction rates were 11% at six months and 30% at 12 months. Initiation of anti-TNF therapy was found to be associated with reduced NSAID use. This pattern was similar as that of GC use except for consumption comparisons in the first episode. Conclusion: Anti-TNF treatment reduced NSAID and GC usage in patients with RA. Evidence of decreased consumption for both medication groups have been reached statistical significance after the first six months of biologic treatment initiation.
Anahtar Kelime:

Konular: Romatoloji
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Donahue KE, Gartlehner G, Jonas DE, Lux LJ, Thieda P, Jonas BL, et al. Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis. Ann Intern Med 2008;148:124-34.
  • 2. A COMPARISON of cortisone and aspirin in the treatment of early cases of rheumatoid arthritis; a report by the Joint Committee of the Medical Research Council and Nuffield Foundation on Clinical Trials of Cortisone, A.C.T.H., and Other Therapeutic Measures in Chronic Rheumatic Diseases. Br Med J 1954;1:1223-7.
  • 3. EMPIRE Rheumatism Council: multi-centre controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis; results of three years' treatment. Ann Rheum Dis 1957;16:277-89.
  • 4. A COMPARISON of prednisolone with aspirin on other analgesics in the treatment of rheumatold rthritis. Ann Rheum Dis 1959;18:173-88.
  • 5. Harris ED Jr, Emkey RD, Nichols JE, Newberg A. Low dose prednisone therapy in rheumatoid arthritis: a double blind study. J Rheumatol 1983;10:713-21.
  • 6. Kirwan JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. N Engl J Med 1995;333:142-6.
  • 7. van Everdingen AA, Jacobs JW, Siewertsz Van Reesema DR, Bijlsma JW. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med 2002;136:1-12.
  • 8. Pirpiris M, Sudhir K, Yeung S, Jennings G, Whitworth JA. Pressor responsiveness in corticosteroid-induced hypertension in humans. Hypertension 1992;19:567-74.
  • 9. Connell JM, Whitworth JA, Davies DL, Lever AF, Richards AM, Fraser R. Effects of ACTH and cortisol administration on blood pressure, electrolyte metabolism, atrial natriuretic peptide and renal function in normal man. J Hypertens 1987;5:425-33.
  • 10. Reid IR. Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinol (Oxf) 1989;30:83-103.
  • 11. van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 2002;13:777-87.
  • 12.Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 2004;141:764-70.
  • 13.Dixon WG, Suissa S, Hudson M. The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses. Arthritis Res Ther 2011;13:R139.
  • 14. Messer J, Reitman D, Sacks HS, Smith H Jr, Chalmers TC. Association of adrenocorticosteroid therapy and peptic-ulcer disease. N Engl J Med 1983;309:21-4.
  • 15.Kyle V, Hazleman BL. Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects. Ann Rheum Dis 1989;48:662-6.
  • 16. Mankin HJ. Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med 1992;326:1473-9.
  • 17. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 2002;46:328-46.
  • 18.Armstrong EP, Malone DC. The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agents. Clin Ther 2003;25:1-18.
  • 19. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002;359:14-22.
  • 20.Lanza FL. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents. Am J Med 1984;77:19-24.
  • 21. Geborek P, Crnkic M, Petersson IF, Saxne T. Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden. Ann Rheum Dis 2002;61:793-8.
  • 22.Seror R, Dougados M, Gossec L. Glucocorticoid sparing effect of tumour necrosis factor alpha inhibitors in rheumatoid arthritis in real life practice. Clin Exp Rheumatol 2009;27:807-13.
  • 23.Naumann L, Huscher D, Detert J, Spengler M, Burmester GR, Buttgereit F. Anti-tumour necrosis factor {alpha} therapy in patients with rheumatoid arthritis results in a significant and long-lasting decrease of concomitant glucocorticoid treatment. Ann Rheum Dis 2009;68:1934-6.
  • 24.Kawai VK, Grijalva CG, Arbogast PG, Curtis JR, Solomon DH, Delzell E, et al. Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2011;63:1415-24.
  • 25.Available from: www.whocc.no/atcddd/
  • 26.Rosen J, Miner JN. The search for safer glucocorticoid receptor ligands. Endocr Rev 2005;26:452-64
APA Birlik M, Çapar S, Akar S, Sari I, ÖNEN F, Akkoç N (2015). Comparison of Glucocorticoid and Nonsteroidal Anti-Inflammatory Drug Requirement Before and After Tumor Necrosis Factor Inhibitor Treatment in Patients With Rheumatoid Arthritis. , 206 - 213.
Chicago Birlik Merih,Çapar Sedat,Akar Servet,Sari Ismail,ÖNEN Fatoş,Akkoç Nurullah Comparison of Glucocorticoid and Nonsteroidal Anti-Inflammatory Drug Requirement Before and After Tumor Necrosis Factor Inhibitor Treatment in Patients With Rheumatoid Arthritis. (2015): 206 - 213.
MLA Birlik Merih,Çapar Sedat,Akar Servet,Sari Ismail,ÖNEN Fatoş,Akkoç Nurullah Comparison of Glucocorticoid and Nonsteroidal Anti-Inflammatory Drug Requirement Before and After Tumor Necrosis Factor Inhibitor Treatment in Patients With Rheumatoid Arthritis. , 2015, ss.206 - 213.
AMA Birlik M,Çapar S,Akar S,Sari I,ÖNEN F,Akkoç N Comparison of Glucocorticoid and Nonsteroidal Anti-Inflammatory Drug Requirement Before and After Tumor Necrosis Factor Inhibitor Treatment in Patients With Rheumatoid Arthritis. . 2015; 206 - 213.
Vancouver Birlik M,Çapar S,Akar S,Sari I,ÖNEN F,Akkoç N Comparison of Glucocorticoid and Nonsteroidal Anti-Inflammatory Drug Requirement Before and After Tumor Necrosis Factor Inhibitor Treatment in Patients With Rheumatoid Arthritis. . 2015; 206 - 213.
IEEE Birlik M,Çapar S,Akar S,Sari I,ÖNEN F,Akkoç N "Comparison of Glucocorticoid and Nonsteroidal Anti-Inflammatory Drug Requirement Before and After Tumor Necrosis Factor Inhibitor Treatment in Patients With Rheumatoid Arthritis." , ss.206 - 213, 2015.
ISNAD Birlik, Merih vd. "Comparison of Glucocorticoid and Nonsteroidal Anti-Inflammatory Drug Requirement Before and After Tumor Necrosis Factor Inhibitor Treatment in Patients With Rheumatoid Arthritis". (2015), 206-213.
APA Birlik M, Çapar S, Akar S, Sari I, ÖNEN F, Akkoç N (2015). Comparison of Glucocorticoid and Nonsteroidal Anti-Inflammatory Drug Requirement Before and After Tumor Necrosis Factor Inhibitor Treatment in Patients With Rheumatoid Arthritis. Archives of Rheumatology, 30(3), 206 - 213.
Chicago Birlik Merih,Çapar Sedat,Akar Servet,Sari Ismail,ÖNEN Fatoş,Akkoç Nurullah Comparison of Glucocorticoid and Nonsteroidal Anti-Inflammatory Drug Requirement Before and After Tumor Necrosis Factor Inhibitor Treatment in Patients With Rheumatoid Arthritis. Archives of Rheumatology 30, no.3 (2015): 206 - 213.
MLA Birlik Merih,Çapar Sedat,Akar Servet,Sari Ismail,ÖNEN Fatoş,Akkoç Nurullah Comparison of Glucocorticoid and Nonsteroidal Anti-Inflammatory Drug Requirement Before and After Tumor Necrosis Factor Inhibitor Treatment in Patients With Rheumatoid Arthritis. Archives of Rheumatology, vol.30, no.3, 2015, ss.206 - 213.
AMA Birlik M,Çapar S,Akar S,Sari I,ÖNEN F,Akkoç N Comparison of Glucocorticoid and Nonsteroidal Anti-Inflammatory Drug Requirement Before and After Tumor Necrosis Factor Inhibitor Treatment in Patients With Rheumatoid Arthritis. Archives of Rheumatology. 2015; 30(3): 206 - 213.
Vancouver Birlik M,Çapar S,Akar S,Sari I,ÖNEN F,Akkoç N Comparison of Glucocorticoid and Nonsteroidal Anti-Inflammatory Drug Requirement Before and After Tumor Necrosis Factor Inhibitor Treatment in Patients With Rheumatoid Arthritis. Archives of Rheumatology. 2015; 30(3): 206 - 213.
IEEE Birlik M,Çapar S,Akar S,Sari I,ÖNEN F,Akkoç N "Comparison of Glucocorticoid and Nonsteroidal Anti-Inflammatory Drug Requirement Before and After Tumor Necrosis Factor Inhibitor Treatment in Patients With Rheumatoid Arthritis." Archives of Rheumatology, 30, ss.206 - 213, 2015.
ISNAD Birlik, Merih vd. "Comparison of Glucocorticoid and Nonsteroidal Anti-Inflammatory Drug Requirement Before and After Tumor Necrosis Factor Inhibitor Treatment in Patients With Rheumatoid Arthritis". Archives of Rheumatology 30/3 (2015), 206-213.